Patents Assigned to Immutep S.A.
  • Compositions containing LAG-3 and cells that secrete GM-CSF and methods of use
    Patent number: 8425897
    Abstract: The present invention relates to a method of enhancing anti-tumor protection in a mammal. More particularly, the invention is concerned with combinations comprising antigen presenting cell (APC) activators and a cytokine-secreting cell and methods of administering the combination for enhanced immune response to tumor cells in a patient with a cancer.
    Type: Grant
    Filed: August 29, 2008
    Date of Patent: April 23, 2013
    Assignee: Immutep S.A.
    Inventors: Karin Jooss, Betty Li, Frederic Triebel
  • APC ACTIVATORS IN COMBINATION WITH A CYTOKINE-SECRETING CELL AND METHODS OF USE THEREOF
    Publication number: 20090130054
    Abstract: The present invention relates to a method of enhancing anti-tumor protection in a mammal. More particularly, the invention is concerned with combinations comprising antigen presenting cell (APC) activators and a cytokine-secreting cell and methods of administering the combination for enhanced immune response to tumor cells in a patient with a cancer.
    Type: Application
    Filed: August 29, 2008
    Publication date: May 21, 2009
    Applicants: Cell Genesys, Inc., Immutep S.A.
    Inventors: Karin Jooss, Betty Li, Frederic Triebel